Vietnam Anti Aging Therapeutics Market Report 2022 to 2030

Vietnam Anti Aging Therapeutics Market Analysis

$ 3999

Vietnam's anti-ageing therapeutics market is expected to witness growth from $3 Mn in 2022 to $10 Mn in 2030 with a CAGR of 16.76% for the forecasted year 2022-30. due to the increasing demand for modern and innovative therapies and associated results for anti-ageing treatment. The Vietnam anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the top players in the market include Imexpharm, Ha Tay Pharmaceutical, and Biosplice.

ID: IN10VNPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Parul Choudhary

Buy Now

Vietnam Anti-Aging Therapeutics Market Executive Summary

Vietnam's anti-ageing therapeutics market is expected to witness growth from $3 Mn in 2022 to $10 Mn in 2030 with a CAGR of 16.76% for the forecasted year 2022-30. From $16.1 Bn in 2017 to $20 Bn in 2021, healthcare expenditure in Vietnam increased steadily. It is expected to reach $23.3 Bn in 2025 and $33.8 Bn in 2030. According to a November report created by Vietnam Report, a Vietnamese business ranking firm, the estimates are based on a compound annual growth rate (CAGR) of 7.6%. The government's initiatives to make healthcare more accessible and affordable, the ageing population of the nation, increased awareness of healthcare requirements, and rising incomes all contribute to this development. According to the company's October-November survey, pharmaceutical companies reported greater year-over-year revenues and profits in the first nine months of the year in 85.7% and 78.6% of cases, respectively.

The use of stem cell therapy to treat degenerative diseases is positive. Since the 1990s, stem cell procedures have been carried out in Vietnam. The Vietnamese government has approved the use of both non-expanded and expanded stem cells for both local and systemic transfusion in some diseases, in contrast to other nations that only sanction the use of non-expanded stem cells. The market has successfully created stem cell banks and some stem cell clinical services after 20 years of stem cell development. Although the government has not yet released some laws or guidelines regarding stem cell applications, recent advancements in stem cell transplantation may make Vietnam more visible as a major player in Asia and, in the near future, globally. Research into novel clinical uses for stem cells has significantly increased since a few stem cell-based medications were recently approved. Both HSCs and MSCs are frequently used to treat specific hematological illnesses in many nations. Aside from hematological illnesses, new stem cell treatments can also be used to treat solid cancers, regenerate bone, treat autoimmune diseases, treat degenerative cartilage damage, and repair bone.

Vietnam Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

The proportion of seniors in Vietnam's population is anticipated to double by 2040 due to the country's rapidly aging population. The demand for anti-aging therapies is being driven by this demographic change as older adults look for methods to keep their health and vitality. Stem cell therapy and hormone replacement therapy are two examples of new and improved anti-aging treatments and therapies that have been made possible by advancements in medical technology.

Market Restraints

The lack of a developed healthcare system in Vietnam may prevent many people from accessing anti-aging therapies and procedures. For firms looking to market novel anti-aging therapies in Vietnam, the regulatory environment can be challenging. The development and marketing of novel therapies can become more expensive and the approval process can be slowed down by complicated regulations and bureaucratic obstacles. The lack of insurance coverage for anti-aging treatments in Vietnam can make them costly and out of reach for a lot of people.

Competitive Landscape

Key Players

Nanogen Pharmaceutical (VNM)
Nam Ha Pharmaceutical (VNM)
LiveSpo Pharma (VNM)
Imexpharm (VNM)
Ha Tay Pharmaceutical (VNM)
Biosplice
Cyclo Therapeutics
Denali Therapeutics
Elysium Health
Genome Protection
GenSight Biologics
Intervene Immune
Khondrian
Longeveron

Healthcare Policies and Regulatory Landscape

The Ministry of Health (MOH) in Vietnam is in charge of overseeing anti-aging medication regulations. All medications sold and promoted in Vietnam must be regulated and approved by the MOH, including anti-aging medications. A regulatory framework for the approval and oversight of medications, including anti-aging medications, has been created by the MOH. Pre-clinical testing, clinical trials, and post-marketing surveillance are just a few of the stages that make up the regulatory procedure. Before being authorized for use in Vietnam, all medications, including anti-aging medications, must pass a stringent evaluation procedure. A review of the drug's efficacy, quality, and safety is part of this process. Following a drug's approval, the MOH conducts post-marketing surveillance to keep an eye on its effectiveness and safety. By monitoring patients, it is possible to spot any potential safety concerns or unfavorable side effects that might appear after a medication has been placed on the market.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

Anti-Wrinkle
Hair Color
Ultraviolet (UV) Absorption
Anti-Stretch Mark
Others

By Treatment (Revenue, USD Billion):

Hair Restoration
Anti-Pigmentation
Adult Acne Therapy
Breast Augmentation
Liposuction
Chemical Peel
Others

By Target Group (Revenue, USD Billion):

Male
Female

By Type of Aging (Revenue, USD Billion):

Cellular Aging
Immune Aging
Metabolic Aging
Others

By Type of Molecules (Revenue, USD Billion):

Biologics
Small Molecules

By Mechanism of Action (Revenue, USD Billion):

Senolytic
Cell Regeneration
mTOR inhibitor/Modulator
AMP-kinase/AMP Activator
Mitochondria Inhibitor/Modulator
Others

By Ingredient (Revenue, USD Billion):

Retinoid
Hyaluronic Acid
Alpha Hydroxy Acid
Others

By Distribution Channel (Revenue, USD Billion):

Pharmacies
Stores
Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.